Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDTX Cidara Therapeutics, Inc.

盘前交易 05-02 07:40:28 EDT

11.81

-0.17

-1.42%

最高11.86	最低11.02	成交量10.77万
今开11.85	昨收11.98	日振幅7.04%
总市值5,387万	流通市值4,545万	总股本456.18万
成交额122.34万	换手率2.80%	流通股本384.85万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDTX","market":"US","secType":"STK","nameCN":"Cidara Therapeutics, Inc.","latestPrice":11.81,"timestamp":1714593600000,"preClose":11.98,"halted":0,"volume":107662,"delay":0,"floatShares":3848459,"shares":4561751,"eps":-5.24572,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.17,"latestTime":"05-02 07:40:28 EDT","open":11.85,"high":11.86,"low":11.0161,"amount":1223423.489058,"amplitude":0.070442,"askPrice":12,"askSize":10,"bidPrice":11.51,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-5.24572,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714656600000},"adr":0,"listingDate":1429070400000,"adjPreClose":11.81,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":11.81,"preClose":11.81,"latestTime":"18:33 EDT","volume":4,"amount":46.08,"timestamp":1714602832432},"volumeRatio":0.36641328387304367},"requestUrl":"/m/hq/s/CDTX/tweets","defaultTab":"tweets","newsList":[{"id":"2432450374","title":"Cidara Therapeutics, Inc.盘中异动 急速跳水5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432450374","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432450374?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:10","pubTimestamp":1714572621,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时10分，Cidara Therapeutics, Inc.股票出现波动，股价大幅下跌5.76%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501221021861ea89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501221021861ea89e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431867407","title":"Cidara Therapeutics, Inc.盘中异动 股价大跌5.46%报11.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431867407","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431867407?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:39","pubTimestamp":1714401560,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时39分，Cidara Therapeutics, Inc.股票出现异动，股价急速跳水5.46%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。该信息摘要如下：Needham：维持Cidara Therapeutics评级，由买入调整至买入评级, 目标价由3.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292239207924f764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292239207924f764&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430677270","title":"Cidara Therapeutics, Inc.盘中异动 快速下挫5.08%报12.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430677270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430677270?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:34","pubTimestamp":1714138453,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时34分，Cidara Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。该信息摘要如下：Needham：维持Cidara Therapeutics评级，由买入调整至买入评级, 目标价由3.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213413861e98a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213413861e98a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430538962","title":"Needham：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由3.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430538962","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430538962?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:25","pubTimestamp":1714069516,"startTime":"0","endTime":"0","summary":"Needham：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由3.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260225188b53f823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260225188b53f823&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430528553","title":"Cidara Therapeutics, Inc.股价上涨15.18% 市值涨980.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430528553","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430528553?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:31","pubTimestamp":1714051883,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时31分，Cidara Therapeutics, Inc.股票出现波动，股价快速拉升15.18%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。消息层面，截至21时31分，《坎托菲茨杰拉德公司：重申Cidara Therapeutics增持评级。》资讯为影响Cidara Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521312387af677e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521312387af677e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429401197","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.29%报0.541美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429401197","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429401197?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879101,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分，Cidara Therapeutics, Inc.股票出现波动，股价快速拉升5.29%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。消息层面，截至21时31分，《坎托菲茨杰拉德公司：重申Cidara Therapeutics增持评级。》资讯为影响Cidara Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314187a65a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314187a65a88&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429921161","title":"坎托菲茨杰拉德公司：重申Cidara Therapeutics(CDTX.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921161","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429921161?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:06","pubTimestamp":1713877571,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Cidara Therapeutics(CDTX.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321061587a64739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321061587a64739&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429590277","title":"Cidara Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2429590277","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429590277?lang=zh_cn&edition=full","pubTime":"2024-04-23 06:11","pubTimestamp":1713823883,"startTime":"0","endTime":"0","summary":"   * Cidara Therapeutics Inc   报告，截至12月底的季度调整后每股亏损4美分，高于去年同期的每股-19美分。四位分析师对该季度的平均预期是每股亏损 10 美分。华尔街预期为每股-16美分至-7美分。* 营收同比增长 72.1%，达到 1758 万美元；分析师预期为 1154 万美元。* Cidara Therapeutics 公司公布的本季度每股收益为亏损 4 美分。* 该公司的季度亏损额为 321 万美元。* Cidara Therapeutics Inc 本季度股价下跌了 26.0%，今年迄今为止下跌了 14.2%。华尔街对 Cidara Therapeutics Inc 的 12 个月目标价中位数为 5.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429921421","title":"Cidara Therapeutics, Inc.盘中异动 股价大跌11.59%报0.602美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921421","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429921421?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:31","pubTimestamp":1713792672,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时31分，Cidara Therapeutics, Inc.股票出现波动，股价大幅跳水11.59%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131128b464e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131128b464e24&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428473346","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅拉升7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428473346","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428473346?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:38","pubTimestamp":1713361113,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时38分，Cidara Therapeutics, Inc.股票出现异动，股价快速上涨7.93%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Igc Pharma, Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.57%、23.39%、20.89%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Igc Pharma, Inc.、Jaguar Health, Inc.，振幅分别为25.30%、19.34%、16.55%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172138337a537bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172138337a537bed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427820465","title":"Cidara Therapeutics, Inc.盘中异动 大幅拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427820465","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427820465?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:32","pubTimestamp":1713274348,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时32分，Cidara Therapeutics, Inc.股票出现异动，股价大幅拉升5.49%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Soligenix, Inc.较为活跃，换手率分别为1072.09%、93.90%、29.18%，振幅较大的相关个股有Palisade Bio, Inc.、Brainstorm Cell Therapeutics Inc.、Marinus Pharmaceuticals, Inc.，振幅分别为23.32%、21.87%、15.38%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132297a532d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132297a532d36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427335006","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨7.41%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427335006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427335006?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187878,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分，Cidara Therapeutics, Inc.股票出现异动，股价大幅上涨7.41%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为582.43%、338.90%、253.45%，振幅较大的相关个股有Organovo Holdings, Inc.、Soligenix, Inc.、Vaxxinity, Inc.，振幅分别为28.71%、16.32%、9.83%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213118877fcb00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213118877fcb00&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427759235","title":"Cidara Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759235","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427759235?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:34","pubTimestamp":1712946845,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时34分，Cidara Therapeutics, Inc.股票出现异动，股价快速下跌5.10%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3669.90%、1448.87%、101.49%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130234057a527b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130234057a527b84&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426269522","title":"Cidara Therapeutics, Inc.盘中异动 早盘急速下挫5.45%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426269522","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426269522?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:02","pubTimestamp":1712847741,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时02分，Cidara Therapeutics, Inc.股票出现波动，股价急速跳水5.45%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。该信息摘要如下：HC Wainwright & Co.：维持Cidara Therapeutics评级，由买入调整至买入评级, 目标价由6.00美元调整至6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112302217a522f8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112302217a522f8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426211189","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅下跌5.61%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426211189","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426211189?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:19","pubTimestamp":1712675941,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日23时19分，Cidara Therapeutics, Inc.股票出现波动，股价急速下挫5.61%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。该信息摘要如下：HC Wainwright & Co.：维持Cidara Therapeutics评级，由买入调整至买入评级, 目标价由6.00美元调整至6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409231901861e443b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409231901861e443b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426947900","title":"HC Wainwright & Co.：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426947900","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426947900?lang=zh_cn&edition=full","pubTime":"2024-04-09 02:34","pubTimestamp":1712601296,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040902345887558295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040902345887558295&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425990145","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅下挫5.01%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425990145","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425990145?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:36","pubTimestamp":1712583392,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时36分，Cidara Therapeutics, Inc.股票出现波动，股价大幅跳水5.01%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Longeveron Inc.、Apollomics Inc C/Wts 01/04/2028 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为518.26%、365.64%、52.29%，振幅较大的相关个股有Longeveron Inc.、泰坦制药、Galmed Pharmaceuticals Ltd.，振幅分别为35.78%、16.79%、13.65%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082136327a51667c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082136327a51667c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424294845","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424294845","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424294845?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:34","pubTimestamp":1712151242,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时34分，Cidara Therapeutics, Inc.股票出现异动，股价大幅拉升6.54%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321340287dae0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321340287dae0fe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422948797","title":"Cidara Therapeutics, Inc.盘中异动 大幅拉升5.41%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422948797","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422948797?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:34","pubTimestamp":1711557279,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时34分，Cidara Therapeutics, Inc.股票出现波动，股价大幅上涨5.41%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3275.28%、1212.38%、75.32%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.，振幅分别为86.96%、78.00%、59.87%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003439861e1ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003439861e1ba3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422523195","title":"Cidara Therapeutics, Inc.盘中异动 股价大跌7.19%报0.721美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422523195","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422523195?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:52","pubTimestamp":1711385532,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日00时52分，Cidara Therapeutics, Inc.股票出现波动，股价快速下挫7.19%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Altamira Therapeutics Ltd.涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为3195.87%、442.09%、76.31%，振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Zura Bio Limited，振幅分别为78.61%、74.57%、47.80%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc是一家生物技术公司。它正在开发用于一线治疗和预防与高死亡率相关的严重侵袭性真菌感染的rezafungin。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032600521287e7b890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032600521287e7b890&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cidara.com","stockEarnings":[{"period":"1week","weight":-0.0391},{"period":"1month","weight":-0.3899},{"period":"3month","weight":-0.0971},{"period":"6month","weight":-0.271},{"period":"1year","weight":-0.4211},{"period":"ytd","weight":-0.2563}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立，2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司，专注于发现，开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类，一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物，CD101，对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内，以前biafungin，一个潜在的每周一次静脉内，或IV，治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品，CD101外用，原名topifungin，是一种外用制剂CD101用于治疗外阴阴道念珠菌病，或VVC，一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外，该公司已开发出专有的免疫治疗技术平台，CloudbreakTM，它用它来创建，旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人，C001，用于治疗侵袭性曲霉病，引起真菌病原体，曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台，传染病等领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.011897},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.058092},{"month":3,"riseRate":0.555556,"avgChangeRate":0.024396},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.08466},{"month":5,"riseRate":0.4,"avgChangeRate":-0.011247},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.009},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.003809},{"month":8,"riseRate":0.444444,"avgChangeRate":0.023347},{"month":9,"riseRate":0.444444,"avgChangeRate":0.030613},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.082612},{"month":11,"riseRate":0.555556,"avgChangeRate":0.006383},{"month":12,"riseRate":0.444444,"avgChangeRate":0.02901}],"exchange":"NASDAQ","name":"Cidara Therapeutics, Inc.","nameEN":"Cidara Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cidara Therapeutics, Inc.,CDTX,Cidara Therapeutics, Inc.股票,Cidara Therapeutics, Inc.股票老虎,Cidara Therapeutics, Inc.股票老虎国际,Cidara Therapeutics, Inc.行情,Cidara Therapeutics, Inc.股票行情,Cidara Therapeutics, Inc.股价,Cidara Therapeutics, Inc.股市,Cidara Therapeutics, Inc.股票价格,Cidara Therapeutics, Inc.股票交易,Cidara Therapeutics, Inc.股票购买,Cidara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}